UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Dr. Doris Chen completed her undergraduate degree in cognitive science at UC Berkeley. She received her medical degree from the University of Nevada School of Medicine and completed her neurology residency training at UC Davis. She is currently a clinical fellow at the UCSF Memory and Aging Center. Her vision is to provide comprehensive and compassionate care for individuals with neurodegenerative disease from all socioeconomic backgrounds.
As an Assistant Professor of Neurology at UCSF, Dr. Lawren Vandevrede's overarching goal is to provide outstanding clinical care to patients with dementia and their caregivers. He completed his medical training in Chicago, where he also obtained a PhD degree in neuroscience working with his mentor to develop novel therapeutic agents for the treatment of Alzheimer’s disease.
Julio Rojas is a neurologist who specializes in dementia, caring for patients with cognitive difficulties or behavioral changes resulting from conditions including Alzheimer’s disease, Lewy body dementia (a form of dementia that causes cognitive defects and Parkinson’s-like symptoms), frontotemporal dementia (a common cause of dementia in younger adults that features behavioral changes) and progressive supranuclear pa
Dr. Peter A. Ljubenkov is a behavioral neurologist at the UCSF Memory and Aging Center and specializes in caring for patients experiencing memory, language and behavioral changes due to neurological conditions, such as Alzheimer’s disease, Lewy body dementia, and other causes of dementia.
Mary Koestler joined the Memory and Aging Center’s clinical trials unit as project administrator and trials nurse in July 2007. Dr. Koestler completed a master’s degree in nursing with an emphasis in clinical research management at UCSF followed by a PhD degree. She currently manages industry-sponsored FDA Phase I-III Alzheimer’s disease trials. Dr. Koestler is credentialed by the Association of Clinical Research Professionals (ACRP).
